Loading…
Lobbying Spend
—
Filings
6
Firms Hired
1
Active Period
2015–2016
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Patients' Access to Treatments Act of 2015
2016 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research at NIAMS & NINDS 21st Century Cures H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Access to Marketplace Insurance Act
2016 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research at NIAMS & NINDS 21st Century Cures H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3742
Patients' Access to Treatments Act of 2015
2015 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research at NIAMS & NINDS 21ST Century Cures H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Access to Marketplace Insurance Act
2015 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research at NIAMS & NINDS 21ST Century Cures H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3742
Patients' Access to Treatments Act of 2015
2015 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research at NIAMS & NINDS 21ST Century Cures
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2015 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research at NIAMS & NINDS 21ST Century Cures
Client expense: — · Firm income: —
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2015 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
H.R. 1600: Patients Access to Treatments Act FDA oversight of new drugs NIH Research
Client expense: — · Firm income: —
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2015 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
BUD: FY16 LHHS Appropriations HCR: H.R. 1600: Patients Access to Treatments Act FDA Oversight of new drugs NIH Research
Client expense: — · Firm income: —
Matched citations: H.R. 1600
Patients' Access to Treatments Act of 2015
2015 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
BUD: FY16 LHHS Appropriations HCR: H.R. 1600: Patients Access to Treatments Act FDA Oversight of new drugs NIH Research
Client expense: — · Firm income: —
Matched citations: H.R. 1600
Source: Senate LDA